title: Could nicotine be beneficial for Behçet's disease?
authors.forename: V G
authors.initials: VG
authors.lastname: Kaklamani
authors.forename: N
authors.initials: N
authors.lastname: Markomichelakis
authors.forename: P G
authors.initials: PG
authors.lastname: Kaklamanis
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D003078:Colchicine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009538:Nicotine / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011446:Prospective Studies; D012907:Smoking; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D009538:Nicotine; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D003078:Colchicine